GlassScriptPhysician profile
James W Harris
NPI 1760445787
$3,531.82
in general payments reported to CMS, 2019-2025
21 companies · $870 in 2025
The $870 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $645 · 2020: $113 · 2021: $183 · 2022: $959 · 2023: $442 · 2024: $320 · 2025: $870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,631.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $840.97 | 2022 | |
| Alcon Vision LLC | $720.86 | 2019-2025 | Hydrus Microstent, Constellation, Total30 |
| Abbvie INC. | $425.67 | 2022-2025 | |
| Aerie Pharmaceuticals, INC. | $240.90 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $212.86 | 2024-2025 | Xiidra, Miebo, Vyzulta |
| Allergan, INC. | $196.22 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $151.41 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $124.38 | 2019-2023 | |
| Lensar, INC. | $103.18 | 2025 | Lensar Laser System |
| Tarsus Pharmaceuticals, INC. | $84.55 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $83.83 | 2019-2021 | |
| Sight Sciences, INC. | $81.92 | 2022-2025 | Omni Surgical System |
| Thea Pharma INC. | $65.34 | 2023-2025 | Iyuzeh |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $56.63 | 2021 | |
| Shire North American Group INC | $38.32 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $34.55 | 2019-2022 | |
| Rayner Intraocular Lenses Limited | $26.47 | 2023 | Rayone Spheric, Omidria, Rayone Aspheric |
| Oyster Point Pharma, INC. | $24.88 | 2023 | Tyrvaya |
| Carl Zeiss Meditec USA, INC. | $18.88 | 2023 | Veracity Surgical |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.